Surgical Outcomes Articles & Analysis
77 news found
Under OBIO’s LSCTC Centre of Excellence’s technology adoption stream, Synaptive Medical will be testing Modus Plan in real-world surgical situations. The focus will be on how easy the software is to use, how well it fits into existing surgical routines, and how it impacts the outcomes of the surgeries performed. ...
Cameron shares invaluable leadership and entrepreneurial insights, reflecting on the journey of founding and growing Synaptive globally, how he leverages artificial intelligence to enhance surgical outcomes and streamline medical procedures, and the importance of data collection in improving patient care and surgical precision. ...
Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. Dennis Kogan, co-founder, and CEO: “Caresyntax celebrated its 10-year anniversary in 2023 and accelerated our journey of innovation ...
With curated data from the entire surgical care process, Medtech industry partners gain meaningful insight into the critical factors that can affect outcomes and improve clinical quality for patients. ...
Proprietary data and software from both platforms will be used to create novel AI-based applications to improve the entire surgical continuum, including medical billing, patient pathway management, and revenue assurance. ...
“Never has virtual reality been a more powerful or viable approach for nurturing highly-trained medical professionals and promoting better surgical outcomes," said Justin Barad, MD, co-founder and CEO of Osso VR. ...
October marks a month dedicated to a cause close to the core of everything which we do at Cirdan: Breast Cancer Awareness. This month will see a surge in activism surrounding breast cancer awareness and a push for finding a cure from around the globe. The fight to treat and cure breast cancer continues constantly, and we pride ourselves in taking part in the fight to save lives. Breast cancer ...
This type of cutting edge translational surgical innovation improves outcomes and ultimately the lives of our patients. ...
TREMIRS aims to improve the currently available surgical robotic systems for both laparoscopy and microsurgery to offer better solutions for patients, improved ergonomics for surgeons and greater performance for surgical teams to ultimately improve the quality of care. ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the publication of the 2022 Annual Letter to Shareholders published in the Company's Proxy Statement for its Annual Meeting ...
Proprio, a medical technology company enabling enhanced surgical performance through the proprietary combination of computer vision, machine learning, and immersive technology, is pleased to announce Dr. ...
“I was impressed by the ActivSight imaging module’s capabilities, specifically its ability to enhance visualization capabilities during surgical procedures. All of the surgeons involved in this study are excited about the promise of the Activ Surgical technology and the potential impact it may have on surgical ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces that the U.S. ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter of fiscal year 2022 ended March 31, 2022. ...
As such, we are excited to inform you that Pelican Feminine Healthcare Ltd trading as Single Use Surgical has now been consolidated and rebranded to Eakin Surgical Ltd. ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective April 4, 2022, the Compensation Committee of the Board of Directors approved an equity award under the ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that a telephone replay of its investor conference call discussing recent disclosures, held yesterday, will be available ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will host a conference call to discuss recent disclosures tomorrow, March 29, 2022, at 10:00 am Eastern Time. ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announced that, effective March 1, 2022, the Compensation Committee of the Board of Directors approved an equity award under the ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders today announces its operating results for the first quarter of fiscal year 2022 ended December 31, 2021. ...